Hyphens Pharma International Limited
Hyphens Pharma International Limited, often referred to as Hyphens Pharma, is a prominent player in the pharmaceutical and healthcare industry, headquartered in Singapore (SG). Established in 2001, the company has made significant strides in providing innovative healthcare solutions across Asia, with a focus on specialty pharmaceuticals and consumer health products. Hyphens Pharma is renowned for its unique portfolio, which includes prescription medicines, over-the-counter products, and nutraceuticals. The company distinguishes itself through strategic partnerships and a commitment to quality, ensuring that its offerings meet the highest standards of efficacy and safety. With a strong market position, Hyphens Pharma has achieved notable milestones, including expanding its operational reach and enhancing its product line to cater to diverse healthcare needs.
DitchCarbon Score
How does Hyphens Pharma International Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hyphens Pharma International Limited's score of 18 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hyphens Pharma International Limited's reported carbon emissions
In 2023, Hyphens Pharma International Limited reported total carbon emissions of approximately 1,309,300 kg CO2e. This figure includes 911,300 kg CO2e from Scope 1 emissions, which primarily stem from mobile combustion and fugitive emissions, and 398,000 kg CO2e from Scope 2 emissions, attributed to purchased electricity. Despite the significant emissions reported, there are currently no specific reduction targets or climate pledges disclosed by the company. This lack of defined initiatives suggests that Hyphens Pharma may be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it will be essential for the company to establish clear commitments to reduce its carbon footprint in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | |
|---|---|
| Scope 1 | 911,300 |
| Scope 2 | 398,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hyphens Pharma International Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
